Bayesian designs to account for patient heterogeneity in ph

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Expert Opinion's
Reply to topic
Bayesian designs to account for patient heterogeneity in ph
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Tue Jun 10, 2008 10:26 am Reply with quote
[img]http://www.co-oncology.com/pt/ServeCoverImage.gif?an=00001622-200807000-00000[/img]

Page: 407
DOI: 10.1097/CCO.0b013e328302163c
Authors: Thall, Peter F; Wathen, J Kyle


Read more...

Source: Current Opinion in Oncology - Current Table Of Contents
Current Opinion in Oncology - July 2008, Volume 20, Issue 4
View user's profileSend private message
Bayesian designs to account for patient heterogeneity in ph
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Expert Opinion's
 Reply to topic  
Forum Map
Site Map